4D Molecular Therapeutics, Inc.: directors' dealings · United States · SEC (Form 4) Explore the full management transaction log of 4D Molecular Therapeutics, Inc., a listed issuer based in United States. Shares trade on US US, under the authority of SEC (Form 4). Market capitalisation: €482.5m. The latest transaction was filed on 2 June 2026 (Cession). Among the most active insiders: Bizily Scott. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 2 June 2026
All Executives50 Thresholds0 Prospectus0 Other0
Declarations 50 total
▼ See Remarks · Executives · 1 Jun 2026
1,922 shares @ US$10.0197 0.4% of flow Common Stock SEC:0001193125-26-253740:0
◇ VP, Finance and Controller · Executives · 20 Mar 2026
865 shares Common Stock SEC:0001193125-26-122341:0
▼ VP, Finance and Controller · Executives · 20 Mar 2026
310 shares @ US$8.61 39.9% of flow Common Stock SEC:0001193125-26-122341:1
◇ VP, Finance and Controller · Executives · 20 Mar 2026
221 shares Common Stock SEC:0001193125-26-122341:2
▼ VP, Finance and Controller · Executives · 20 Mar 2026
80 shares @ US$8.61 10.3% of flow Common Stock SEC:0001193125-26-122341:3
◇ VP, Finance and Controller · Executives · 20 Dec 2025
866 shares Common Stock SEC:0001193125-25-331299:0
▼ VP, Finance and Controller · Executives · 20 Dec 2025
310 shares @ US$8.68 39.7% of flow Common Stock SEC:0001193125-25-331299:1
◇ VP, Finance and Controller · Executives · 20 Dec 2025
220 shares Common Stock SEC:0001193125-25-331299:2
▼ VP, Finance and Controller · Executives · 20 Dec 2025
79 shares @ US$8.68 10.1% of flow Common Stock SEC:0001193125-25-331299:3
◇ Director · Executives · 12 Dec 2025
9,333 shares @ US$1.14 100.0% of flow Common Stock SEC:0001193125-25-320992:0
▼ Chief Legal Officer · Executives · 9 Oct 2025
2,408 shares @ US$10.00 4.8% of flow Common Stock SEC:0001193125-25-238995:0
535,000 shares 0Common Stock SEC:0001415889-24-028837:0
3,062,000 shares Common Stock, $0.0001 par value SEC:0000921895-24-002631:0
◇ Chief Legal Officer · Executives · 16 Sept 2024
500 shares @ US$6.49 0.7% of flow Common Stock SEC:0000950170-24-107903:0
◇ Chief Legal Officer · Executives · 19 Aug 2024
500 shares @ US$6.49 0.7% of flow Common Stock SEC:0000950170-24-099505:0
◇ Chief Legal Officer · Executives · 16 Jul 2024
500 shares @ US$6.49 0.7% of flow Common Stock SEC:0000950170-24-084725:0
◇ Chief Legal Officer · Executives · 11 Jul 2024
1,996 shares @ US$15.78 6.7% of flow Common Stock SEC:0000950170-24-083712:0
◇ Chief Executive Officer · Executives · 10 Jul 2024
11,653 shares @ US$14.42 3.5% of flow Common Stock SEC:0000950170-24-083303:0
◇ Chief Legal Officer · Executives · 1 Jul 2024
1,332 shares @ US$6.49 1.9% of flow Common Stock SEC:0000950170-24-081626:0
◇ Chief Executive Officer · Executives · 24 Jun 2024
12,930 shares @ US$14.42 3.9% of flow Common Stock SEC:0000950170-24-077944:0
◇ Chief Legal Officer · Executives · 17 Jun 2024
500 shares @ US$6.49 0.7% of flow Common Stock SEC:0000950170-24-075692:0
◇ Chief Legal Officer · Executives · 16 May 2024
500 shares @ US$6.49 0.7% of flow Common Stock SEC:0000950170-24-062637:0
◇ Chief Legal Officer · Executives · 16 Apr 2024
500 shares @ US$6.49 0.7% of flow Common Stock SEC:0000950170-24-045702:0
◇ Chief Legal Officer · Executives · 1 Apr 2024
1,332 shares @ US$6.49 1.9% of flow Common Stock SEC:0000950170-24-041418:0
◇ Chief Legal Officer · Executives · 27 Mar 2024
4,342 shares @ US$25.98 24.0% of flow Common Stock SEC:0000950170-24-038731:0
25 of 50 declarations
Load more (25 remaining)